Early minimal residual disease assessment after AML induction with fludarabine, cytarabine and idarubicin (FLAI) provides the most useful prognostic information

Creators

• MINETTO, PAOLA
• GUOLO, FABIO
• Clavio, Marino
• Kunkl, Annalisa
• COLOMBO, NICOLETTA
• Carminati, Enrico
• Fugazza, Giuseppina
• MATARESE, SIMONA
• GUARDO, DANIELA
• BALLERINI, FILIPPO
• Di Grazia, Carmen
• Raiola, Anna M.
• Cagnetta, Antonia
• Cea, Michele
• Miglino, Maurizio
• LEMOLI, ROBERTO MASSIMO
• Gobbi, Marco

Contributors